Grayslake, IL, United States of America

Richard L Elliott


Average Co-Inventor Count = 6.4

ph-index = 4

Forward Citations = 81(Granted Patents)


Company Filing History:


Years Active: 1995-2001

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Inventive Journey of Richard L. Elliott in the Field of Pharmaceuticals

Introduction: Richard L. Elliott, a prolific inventor based in Grayslake, IL, has made significant contributions to the pharmaceutical industry with a total of 7 patents under his belt. His innovative spirit and dedication to advancing medical science have earned him recognition in the field of drug development.

Latest Patents: Among his latest patents are revolutionary compounds such as Tricyclic erythromycin derivatives and novel heterocyclic ether compounds. These inventions have shown promise in controlling chemical synaptic transmission, offering new possibilities for therapeutic interventions in mammals.

Career Highlights: Richard L. Elliott is affiliated with Abbott Laboratories Corporation, a prominent pharmaceutical company known for its groundbreaking research and development initiatives. His association with Abbott Laboratories Corporation has provided him with the resources and platform to bring his inventive ideas to fruition.

Collaborations: Throughout his career, Richard L. Elliott has collaborated with esteemed professionals in the industry, including Nan-Horng Lin and Mark W. Holladay. These collaborations have not only enhanced the scope of his work but have also fostered a culture of innovation and knowledge-sharing within the pharmaceutical community.

Conclusion: In conclusion, Richard L. Elliott's journey as an inventor in the pharmaceutical sector showcases his commitment to driving advancements in medical science. With a portfolio of patents that reflect his creative thinking and scientific expertise, he continues to inspire future generations of inventors in the quest for improved healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…